Fox Jennifer A.
SEC insider (Form 3/4/5 filer). CIK 0001841557. Director at Apogee Therapeutics, Inc. (APGE) and 2 other issuers. 11 reported Form 4/5 transactions since Sep 2024; latest on Sep 3, 2026. Located in SAN FRANCISCO, CA.
Companies Fox Jennifer A. has filed insider reports for
- Apogee Therapeutics, Inc. (APGE): Director
- Zenas BioPharma, Inc. (ZBIO): Officer, See Remarks
- PROKIDNEY CORP. (PROK): Director
Fox Jennifer A.
CIK: 0001841557
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Sep 3, 2026APGE
Apogee Therapeutics, Inc.
DispositionDirect34.8K shares- - Jun 15, 2026ZBIO
Zenas BioPharma, Inc.
AwardDirectStock Option (Right to Buy)
125K shares- - Jun 9, 2026APGE
Apogee Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
7.7K shares- - May 28, 2026PROK
PROKIDNEY CORP.
AwardDirectDirector stock option (right to buy)
135K shares- - Feb 5, 2026ZBIO
Zenas BioPharma, Inc.
AwardDirect1.6K shares at avg. $13.35$21K - Jun 17, 2025APGE
Apogee Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
14.5K shares- - Jun 10, 2025ZBIO
Zenas BioPharma, Inc.
AwardDirectStock Option (Right to Buy)
150K shares- - May 29, 2025PROK
PROKIDNEY CORP.
AwardDirectDirector stock option (right to buy)
125.9K shares- - Dec 16, 2024ZBIO
Zenas BioPharma, Inc.
AwardDirectStock Option (Right to Buy)
8.1K shares- - Sep 12, 2024ZBIO
Zenas BioPharma, Inc.
AwardDirectStock Option (Right to Buy)
155K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 3, 2026 |  APGE Apogee Therapeutics, Inc. | Disposition | 34,824 | - | $0 | Direct |
| Jun 15, 2026 |  ZBIO Zenas BioPharma, Inc. | Award Stock Option (Right to Buy) | 125,000 | - | - | Direct |
| Jun 9, 2026 | APGE Apogee Therapeutics, Inc. | Award Stock Option (Right to Buy) | 7,657 | - | - | Direct |
| May 28, 2026 |  PROK PROKIDNEY CORP. | Award Director stock option (right to buy) | 135,000 | - | - | Direct |
| Feb 5, 2026 | ZBIO Zenas BioPharma, Inc. | Award | 1,592 | $13.35 | $21,253 | Direct |
| Jun 17, 2025 | APGE Apogee Therapeutics, Inc. | Award Stock Option (Right to Buy) | 14,461 | - | - | Direct |
| Jun 10, 2025 | ZBIO Zenas BioPharma, Inc. | Award Stock Option (Right to Buy) | 150,000 | - | - | Direct |
| May 29, 2025 | PROK PROKIDNEY CORP. | Award Director stock option (right to buy) | 125,862 | - | - | Direct |
| Dec 16, 2024 | ZBIO Zenas BioPharma, Inc. | Award Stock Option (Right to Buy) | 8,125 | - | - | Direct |
| Sep 12, 2024 | ZBIO Zenas BioPharma, Inc. | Award Stock Option (Right to Buy) | 155,000 | - | - | Direct |
1-10 of 11 transactions